We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+24.56%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$467B
AUM Growth
+$83.7B
Cap. Flow
+$2.63B
Cap. Flow %
0.56%
Top 10 Hldgs %
22.59%
Holding
4,219
New
118
Increased
2,550
Reduced
1,055
Closed
119

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$524M
2
META icon
Meta Platforms (Facebook)
META
+$458M
3
OTIS icon
Otis Worldwide
OTIS
+$345M
4
TMUS icon
T-Mobile US
TMUS
+$307M
5
ABBV icon
AbbVie
ABBV
+$280M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$878M
2
RTN
Raytheon Company
RTN
+$537M
3
BMY icon
Bristol-Myers Squibb
BMY
+$435M
4
AAPL icon
Apple
AAPL
+$389M
5
ACN icon
Accenture
ACN
+$216M

Sector Composition

Rank Sector Weight
1 Technology 23.72%
2 Healthcare 14.52%
3 Financials 12.98%
4 Consumer Discretionary 10.98%
5 Communication Services 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTNP
3701
DELISTED
Titan Pharmaceuticals
TTNP
$158K ﹤0.01%
860
+121
+16% +$20.8K
CGRN
3702
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$158K ﹤0.01%
52,484
REED
3703
DELISTED
Reeds, Inc. Common Stock
REED
$158K ﹤0.01%
3,310
CLS icon
3704
Celestica
CLS
$38.1B
$157K ﹤0.01%
23,011
-12,057
-34% -$69K
CZWI icon
3705
Citizens Community Bancorp
CZWI
$212M
$157K ﹤0.01%
22,945
+611
+3% +$4.27K
SPRT
3706
DELISTED
support.com, Inc.
SPRT
$157K ﹤0.01%
111,827
AP icon
3707
Ampco-Pittsburgh
AP
$163M
$156K ﹤0.01%
51,041
IGC icon
3708
IGC Pharma
IGC
$26M
$156K ﹤0.01%
261,671
MFGP
3709
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
$156K ﹤0.01%
28,687
+15,854
+124% +$86.8K
VRN
3710
DELISTED
Veren
VRN
$155K ﹤0.01%
96,047
+25,105
+35% +$34.7K
SEEL
3711
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$155K ﹤0.01%
40
YGYI
3712
DELISTED
Youngevity International, Inc Common Stock
YGYI
$155K ﹤0.01%
108,757
-7,703
-7% -$12K
RNWK
3713
DELISTED
RealNetworks Inc
RNWK
$155K ﹤0.01%
119,336
OTLK icon
3714
Outlook Therapeutics
OTLK
$183M
$154K ﹤0.01%
5,975
+2,613
+78% +$46.6K
NEPT
3715
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$154K ﹤0.01%
40
-15
-27% -$50.4K
GLBZ
3716
DELISTED
Glen Burnie Bancorp
GLBZ
$153K ﹤0.01%
18,661
NAVB
3717
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$153K ﹤0.01%
38,979
+2,970
+8% +$5.68K
FSM icon
3718
Fortuna Silver Mines
FSM
$2.55B
$152K ﹤0.01%
30,183
+900
+3% +$3.25K
IMH
3719
DELISTED
Impac Mortgage Holdings Inc.
IMH
$152K ﹤0.01%
90,195
SNDA icon
3720
Sonida Senior Living
SNDA
$1.91B
$151K ﹤0.01%
14,211
IDXG
3721
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$151K ﹤0.01%
32,476
IMBI
3722
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$150K ﹤0.01%
43,331
STIM icon
3723
Neuronetics
STIM
$138M
$149K ﹤0.01%
77,462
-83,392
-52% -$171K
TUSK icon
3724
Mammoth Energy Services
TUSK
$128M
$149K ﹤0.01%
126,883
-89,104
-41% -$103K
CHPM
3725
DELISTED
CHP Merger Corp. Class A Common Stock
CHPM
$149K ﹤0.01%
+15,000
New +$147K

Similar funds

Geode Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
  • Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
  • Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
  • Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
  • Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
  • Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
  • Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.

Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.